FDA Approves Mirdametinib for Neurofibromatosis Type 1
The US Food and Drug Administration (FDA) has approved mirdametinib (Gomekli, SpringWorks Therapeutics, Inc.) for certain adult and pediatric patients...
Becki Mote
Chiefs DE George Karlaftis Uses Routine to Unleash His Pass Rushing Power
KANSAS CITY CHIEFS defensive end George Karlaftis has been here before. Twice, actually. The 23-year-old has played in (and won)...
